Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Treatment approaches for desmoid tumours

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.10.12
Views: 5057
Rating:

Dr Sylvie Bonvalot – Institut Gustave Roussy, Paris, France

Dr Sylvie Bonvalot talks with ecancer at the 2012 ESMO meeting in Vienna about the strategy of treatment for desmoid tumours.

Desmoid tumours, a rare type of aggressive tumour, can present in almost any part of the body.

The most important part of diagnosis for this tumour type is testing for a beta kinase mutation that 95% of patients have. 

The main advances come specifically in altering strategy on approaching treatment as half of patients receiving treatment cannot continue after the first course because of adverse side effects.

 

Filming supported by Amgen

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation